Drug Delivery Insights From A 30-Year Veteran At 3M

By Ed Miseta, Chief Editor, Clinical Leader

James Ingebrand, president and general manager for 3M (NYSE: MMM) Drug Delivery Systems, joined 3M back in 1984. Having worked across a number of 3M’s divisions in the United States and the United Kingdom, both on the branded and OEM sides of the business, Ingebrand has rich insight into industry trends as well as 3M’s history of innovation. From Ingebrand’s perspective, the culture of innovation continues into the drug delivery area by leveraging the company’s expertise and vast technological capabilities. Ingebrand sat down with Outsourced Pharma (OP) to share his insights into key trends and how the 3M culture is positioned to capitalize on them.